קטופרוסול וטרינרי ישראל - עברית - Ministry of Health

קטופרוסול וטרינרי

hachaklait ltd - ketoprofen - תמיסה להזרקה - ketoprofen 100 mg / 1 ml

CP קרם חמצן 6% ישראל - עברית - Ministry of Health

cp קרם חמצן 6%

ג'ויה מעבדות לקוסמטיקה בעמ - רעיש תעיבצל עייסמ

CP קרם חמצן 9% ישראל - עברית - Ministry of Health

cp קרם חמצן 9%

ג'ויה מעבדות לקוסמטיקה בעמ - רעיש תעיבצל עייסמ

רוורטור וטרינרי ישראל - עברית - Ministry of Health

רוורטור וטרינרי

a.veterinary supply ltd - atipamezole hydrochloride - תמיסה להזרקה - atipamezole hydrochloride 5 mg / 1 ml

טרייזנוקס ישראל - עברית - Ministry of Health

טרייזנוקס

medison pharma ltd - arsenic trioxide - תמיסה להזרקה - arsenic trioxide 1 mg/ml - arsenic trioxide - arsenic trioxide - induction of remission and consolidation in patients with acute promyelocytic leukemia (apl) who are refractory to or have relapsed from retinoid and anthracycline chemotherapy, and whose apl is characterized by the presence of the translocation of pml/rar-alpha gene expression.

קלופידוגרל טבע ישראל - עברית - Ministry of Health

קלופידוגרל טבע

teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

הפטקט CP ישראל - עברית - Ministry of Health

הפטקט cp

kamada ltd, israel - human hepatitis b immunoglobulin - תמיסה לאינפוזיה - human hepatitis b immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - prophylaxis against hepatitis b in adults and children over 2 years of age who have not been vaccinated against hepatitis b (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis b by accidental contact with hepatitis b virus containing material following: - percutaneous exposure (e.g. accidental needle stick). - direct mucous membrane contact. when the administration of an intramuscular hepatitis b immunoglobulin is not possible. the immunoglobulin should be administered in association with hepatitis b vaccine. prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis b virus. immunoprophylaxis of hepatitis b in the newborn of a hepatitis b virus carrier mother.

מגלוטקט CP ישראל - עברית - Ministry of Health

מגלוטקט cp

kamada ltd, israel - cytomegalovirus antibody; human plasma protein; immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 96 %; human plasma protein 50 mg/ml; cytomegalovirus antibody 100 u/ml - cytomegalovirus immunoglobulin

קלופידוגרל טבע  ישראל - עברית - Ministry of Health

קלופידוגרל טבע

teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel